News FDA's Duchenne drug approval greeted with joy, but remains c... FDA will require efficacy evidence.
Views & Analysis Regulatory timelines in the Asia-Pacific Snapshot of clinical trial application processes in the region.
Views & Analysis Are European incentives speeding access in rare cancer treat... Examining the impact of support programmes for orphan treatments.
News UK could quit EU drug regulation system - minister Nothing has been ruled in or out, says George Freeman.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
